Oliver Wright, solicitor at law firm LHS, says a new high court ruling means improved transparency and a clearer framework for companies operating under regulation by the Health Research Authority
Novozymes Biopharma, part of Novozymes A/S, announced that an ophthalmic solution made using its recombinant human albumin has been approved for Phase I/II development by the FDA.
